Compare Figma Inc. Class A Common Stock (FIG) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figma Inc. Class A Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Figma Inc. Class A Common Stock trades at $21.33 (market cap $11.45B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Figma Inc. Class A Common Stock is far larger — about 7.9× uniQure N.V. Ordinary Shares's market cap, and Figma Inc. Class A Common Stock is more actively traded (12,424,893 versus 3,323,243). Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| FIG | QURE | |
|---|---|---|
Market Cap | $11.45B | $1.45B |
Volume | 12,424,893 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $63.82 | $70.59 |
52-Week Low | $16.84 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.85B | $707.46M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figma Inc. Class A Common Stock
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
